Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 4
2006 4
2007 6
2008 5
2009 3
2010 4
2011 13
2012 10
2013 5
2014 12
2015 17
2016 14
2017 9
2018 12
2019 8
2020 13
2021 13
2022 10
2023 20
2024 9
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.
Kim CG, Jung M, Kim HS, Lee CK, Jeung HC, Koo DH, Bae WK, Zang DY, Kim BJ, Kim H, Yun UJ, Che J, Park S, Kim TS, Kwon WS, Park J, Cho SW, Nam CM, Chung HC, Rha SY. Kim CG, et al. Among authors: koo dh. J Clin Oncol. 2023 Sep 20;41(27):4394-4405. doi: 10.1200/JCO.22.02122. Epub 2023 Jun 26. J Clin Oncol. 2023. PMID: 37364218
Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4).
Kang YK, Ryu MH, Oh DY, Oh SC, Rha SY, Lee KW, Chung IJ, Oh SY, Sym SJ, Kang WK, Kim JG, Shim BY, Kim IH, Kim JY, Song EK, Lee HJ, Kang SY, Koo DH, Oh SY. Kang YK, et al. Among authors: koo dh. Cancer Res Treat. 2025 Jul 2. doi: 10.4143/crt.2024.913. Online ahead of print. Cancer Res Treat. 2025. PMID: 40610007 Free article.
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).
Lim SH, Lee KW, Kim JJ, Im HS, Kim IH, Han HS, Koo DH, Cho JH, Maeng CH, Lee MY, Lee HJ, Kim JH, Park SG, Jung JY, Shin SH, Kim KH, Kim H, Oh SY, Kang M, Jung M, Rha SY. Lim SH, et al. Among authors: koo dh. BMC Cancer. 2024 Feb 23;24(1):252. doi: 10.1186/s12885-024-11972-w. BMC Cancer. 2024. PMID: 38395832 Free PMC article.
Non-Operative Management of Rectal Cancer with Adjuvant Chemotherapy after Chemoradiotherapy (NORMANDY): Prospective Study.
Lee H, Kim HO, Lee JJB, Do IG, Kwon HJ, Kim MS, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Jung KU, Kim EJ, Koo DH, Kim H, Chun HK; KBSMC Colorectal Cancer Team, Gastrointestinal Cancer Center. Lee H, et al. Among authors: koo dh. Cancer Res Treat. 2025 May 15. doi: 10.4143/crt.2025.148. Online ahead of print. Cancer Res Treat. 2025. PMID: 40400182 Free article.
Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.
Lee K, Lee KH, Kim DW, Yoon J, Choi YJ, Lee S, Kim JW, Park KH, Choi W, Lee Y, Ryu H, Koo DH, Lee Y, Jeung HC, Lee MY, Lee N, Kang MJ, Lee J, Hong SH, Kang EJ, Park IH. Lee K, et al. Among authors: koo dh. Cancer Commun (Lond). 2025 Jul;45(7):841-845. doi: 10.1002/cac2.70026. Epub 2025 Apr 11. Cancer Commun (Lond). 2025. PMID: 40211931 Free PMC article. No abstract available.
Recent trends in studies of biomolecular phase separation.
Kim CG, Hwang DE, Kumar R, Chung M, Eom YG, Kim H, Koo DH, Choi JM. Kim CG, et al. Among authors: koo dh. BMB Rep. 2022 Aug;55(8):363-369. doi: 10.5483/BMBRep.2022.55.8.101. BMB Rep. 2022. PMID: 35880435 Free PMC article.
171 results